TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 6, 2024
Sitryx Therapeutics Makes Key Sppointments to Dtrengthen Business Operations and Progress Immunometabolism-Targeting Pipeline into Clinical Development March 5, 2024
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 February 26, 2024
